Stereochemistry is vital for pharmaceutical development and can determine drug efficacy. Herein, 10 pairs of asymmetric triplex metallohelix enantiomers as a library were used to screen inhibitors of amyloid b (Ab) aggregation via a fluorescent cell-based high-throughput method. Intriguingly, L enantiomers show a stronger inhibition effect than D enantiomers. In addition, the metallohelices with aromatic substituents are more effective than those without, revealing that these groups play a key role in the Ab interaction. Fluorescence stopped-flow kinetic studies indicate that binding of the L enantiomer to Ab is much faster than that of the D enantiomer. Furthermore, studies in enzyme digestion, isothermal titration calorimetry, nuclear magnetic resonance, and computational docking demonstrate that the enantiomers bind to the central hydrophobic a-helical region of Ab13-23, although with different modes for the L and D enantiomers. Finally, an in vivo study showed that these metallohelices extend the life span of the Caenorhabditis elegans CL2006 strain by attenuating Ab-induced toxicity. Our work will shed light on the design and screening of a metal complex as an amyloid inhibitor against Alzheimer's disease.
INTRODUCTION
Supramolecular chemistry aims at building functional, highly complex chemical systems from components assembled by intermolecular forces (1) . It offers an outstanding methodology for the design and synthesis of complex arrays at the molecular level (1, 2) . Certain self-assembling multimetallic coordination complexes, named helicates, can have a similar size to a-helical peptides, particularly in terms of their diameter and charge (3, 4) , and this can lead to specific target-binding affinity with biomolecules (5) . Recently, the application of the supramolecular helical scaffold has received much attention, including studies on asymmetric catalysis (6) , antimicrobials (3), anticancer (4, 7) , and the targeting of amyloid b (Ab) for the treatment of Alzheimer's disease (AD) (5) . AD, the most prevalent age-related dementia, affects more than 30 million people worldwide, and it is estimated that, by 2050, some 106 million people will be afflicted with the disease (8, 9) . However, the exact cause of AD, as well as the molecular mechanisms involved, has not been fully understood. Emerging evidence has shown that the origin of neurotoxicity is closely linked to the aggregate process of Ab monomers to oligomers and then subsequently to fibrils in the pathogenesis (10, 11) . Therefore, immense attention has been paid toward inhibiting Ab aggregation (12) (13) (14) (15) (16) as an effective preventive and therapeutic method for the treatment of AD. Although considerable achievements have been made in screening inhibitors of Ab aggregation and toxicity, the complex interactions involved in Ab aggregation dynamics and morphology (17) are difficult to address using conventional small molecules. Therefore, chiral recognition of the supramolecular structures may be key to developing an understanding of the disease and discovering new treatments.
Recent studies have demonstrated that forming a-helical intermediates facilitates fibrillization (18) (19) (20) . An a-helical structure in the 13 to 23 segment of Ab is predicted to become a b strand identified as an a/b discordance (21) . Because an Ab analog that lacks residues 13 to 23 and results in deficiency of the a/b discordant stretch does not form detectable amyloid fibrils (22) , there may be a causal connection between a/b discordance and fibril structure. Emerging evidence suggested that stabilization of helical motif(s) may be a suitable target for screening inhibitors of Ab aggregation (5, 23) . Therefore, chiral supramolecules that are capable of binding the a-helical form may exhibit enantioselectivity on inhibition of Ab aggregation.
As previously reported, chiral helicates, which are synthesized by symmetric rigid ligands AB-BA (Fig. 1A) , can be potential therapeutic agents (8) for enantioselectively inhibiting Ab aggregation. However, this symmetric system offers little scope to adjust the structure to interact with Ab or to create a library for screening Ab aggregation inhibitors resulting from the high symmetry and modest functionality of the system. Recently, we developed a new strategy whereby directional ligands AB-CD were used to synthesize optically pure head-to-head-to-tail (HHT) asymmetric constitutions in the absence of head-to-head-tohead (HHH) isomers (Fig. 1B) . Herein, we strategically prepared a highly stereoselective self-assembly of diverse, functionalized metallohelices with this HHT structure to enantioselectively inhibit Ab aggregation. These metallohelices have amphipathic topology and high, structure-dependent, selective biological activity. Using a cell-based high-throughput screening system, these asymmetric triplex metallohelices enantioselectively inhibited Ab aggregation. Our work shows that these metallosupramolecules can act as Ab inhibitors, specifically targeting the central hydrophobic a/b discordant stretch.
RESULTS AND DISCUSSION
Ten pairs of HHT asymmetric metallohelix enantiomers (Fig. 1, C and D) were synthesized and characterized according to our previously reported methods (3, 4) and used to screen inhibitors of Ab aggregation by a cell-based high-throughput screening method ( Fig. 2A ) (5) . The high-throughput screen system is constructed by a fusion of Ab42 to enhanced cyan fluorescent protein (Ab-ECFP). In general, Ab42 in the Ab-ECFP fusion system aggregates rapidly, which hinders ECFP folding into its native structure to emit cyan fluorescence. In the presence of Ab aggregation inhibitors, ECFP in the Ab-ECFP fusion system folds into its native structure and emit cyan fluorescence. ECFP, a non-Ab fusion system, was used as a control in our experiments. Almost no fluorescence enhancements were observed for the non-Ab fusion system with the incubation of metallohelices ( fig. S1 ). Screening results are shown in Fig. 2 (B and C) , and the inhibition ability of the complex can be estimated by the related fluorescence value of Ab-ECFP/ECFP. Intriguingly, LA1 and DA1 showed remarkable enantiomeric differences on inhibition of Ab aggregation, whereas LB4 and DB4 had the greatest inhibition effect. Therefore, we selected these two pairs of A1 and B4 as examples for further study.
To investigate the effect of the metallohelices on Ab aggregation kinetics, we performed a thioflavin T (ThT) fluorescence assay. This is a widely used assay to study the formation of amyloid fibrils (24) (25) (26) . Under our experimental conditions, metallohelices alone did not affect ThT fluorescence ( fig. S2 ). Kinetic analysis of the ThT assay showed that ThT fluorescence did not increase in the early stages, thus demonstrating that the aggregation of Ab40 and Ab42 was greatly suppressed with the incubation of metallohelices (Fig. 2D and fig. S3 ). Free ligands L a1 and L
b4
, which are components of A1 and B4, showed little inhibition effect on Ab40 aggregation ( fig. S4 ). Fluorescence stopped-flow kinetic studies (Fig. 2E) showed that the process of LA1 binding to Ab40 was completed about 0.04 s under our experimental conditions, which was five times faster than its enantiomer DA1 (about 0.2 s).
Herein, we compared the fibrillation inhibitors mentioned in Introduction with the metallohelices used in our study. In comparison with peptide-organic molecule coassemblies (12) , the metallohelices in our study exhibited better inhibition effect. With 50 mM peptideorganic molecule coassemblies, the inhibition ratio was 70%. In our study, the inhibition ratio was up to 80% with 50 mM LB4. Among the fibrillation inhibitors discussed in Introduction, CdTe nanoparticles (NPs) (15) performed the best inhibition effect. The intensity of ThT can be decreased by 80% with only 2.5 mM CdTe NPs. With 25 mM inhibitors, the inhibition ratios were 63 and 80% with polyoxometalate (POM)/peptide composites (POM@P) (13) and POM-Dawson derivatives (14) , respectively. On the basis of the inhibition efficiency, CdTe NPs and POM@P exhibited better inhibition effect than the metallohelices used in our study. This could be because one NP may offer many active sites for interacting with Ab, whereas one metallohelix can only offer one active site per molecule. Although these NPs have better inhibition activity, NPs are easily aggregated and accumulated in the body because of their hard degradation. For metallohelices, they are stable and highly water-soluble compared to peptide-organic molecules and NPs, and the structures and stereochemistry of metallohelices are adjustable and optimized. They can specifically bind to the central hydrophobic a-helical region of Ab13-23, showing the potential for AD treatment.
Median inhibitory concentration (IC 50 ) values can also be estimated by ThT fluorescence assay (8) . As shown in fig. S5 , metallohelices A1 and B4 can inhibit Ab40/Ab42 aggregation in a dose-dependent manner. For Ab40, IC 50 values were 3.65 mM for LA1, 32.29 mM for DA1, 0.94 mM for LB4, and 2.55 mM for DB4 (table S1). For Ab42, IC 50 values were 6.76 mM for LA1, 69.82 mM for DA1, 1.66 mM for LB4, and 3.72 mM for DB4. These results demonstrated that LA1 and LB4 had stronger inhibition on Ab40/Ab42 aggregation than their enantiomers DA1 and DB4. Furthermore, the enantioselectivity of A1 was higher than that of B4. Therefore, there were two features for the metallohelices to inhibit Ab aggregation. First, the L enantiomers showed higher inhibition effects than the D enantiomers. Second, the metallohelices with aromatic substituents are more effective than those without aromatic substituents.
To better compare the inhibitory effects of the asymmetric triplex metallohelices and the previously reported symmetric systems, we summarized their IC 50 values in table S1. The asymmetric metallohelix LB4 showed a higher inhibition effect than the symmetric architectures, whereas the chiral discrimination of A1 is the most obvious. This may be due to the nature of the asymmetric fold of the triplex metallohelices, which creates a distinctly amphipathic architecture, reminiscent of a-helical peptides (4).
We also investigated the inhibition of Ab40 aggregation by an SDS-polyacrylamide gel electrophoresis (PAGE) assay (27, 28) . After the incubation of Ab40 with metallohelices at 37°C, we separated the high-molecular weight Ab40 aggregates and the low-molecular weight Ab40 species by centrifugation. The aggregated peptide pellets were resuspended in sample buffer and then boiled with SDS for 10 min to destroy the secondary and tertiary structures. The total amounts of aggregated Ab40 were estimated by the SDS-PAGE assay. After incubation with metallohelices A1 and B4, the amount of the resuspended peptide was decreased ( fig. S6 ). SDS-PAGE results indicated that these metallohelices inhibited Ab aggregation.
To further study the morphology of Ab40 and Ab42 aggregates affected by these metallohelices, we carried out an atomic force microscopy (AFM) study (29, 30) . In samples of Ab40 or Ab42 alone, traditional nonbranched amyloid fibrils (helical filaments with diameters of about 10 nm and lengths of up to several micrometers) were observed ( Fig. 3, control) . After incubating Ab40 or Ab42 with the metallohelices, particularly LB4, numerous small, globular dots can be observed, suggesting the excellent efficacy of metallohelices in inhibiting the aggregation of Ab40 and Ab42 (Fig. 3) .
Ab40/Ab42 aggregation involves formation of b sheet-rich frameworks, which can be determined by circular dichroism (CD; a wide band near 217 nm). We calculated the proportional contribution of the b sheet structure in the samples of Ab40 according to previous reports (31, 32) . On average, the Ab40 fibrils contained approximately 57 ± 5% of b sheet structure, which decreased to 29 ± 3%, 35 ± 4%, 19 ± 3%, and 23 ± 4% on incubation with LA1, DA1, LB4, and DB4, respectively (Fig. 4 , A and B). As shown in fig. S7 , the metallohelices had a similar effect on Ab42. This indicates that the metallohelices inhibit significant structural change in Ab40. To reveal the enantiomeric selectivity of metallohelix enantiomers, we performed dialysis experiments (33) . Racemic mixtures of A1 and B4 were dialyzed against Ab40. In addition, the enhanced sign of CD was attributed to the left enantiomer with lower binding affinity to Ab40. As shown in Fig. 4 (C and D), the dialyzate was rich in DA1 and DB4, which unambiguously indicated that LA1 and LB4 preferentially bind to Ab40 compared with their enantiomers.
The four metallohelices showed different inhibiting capacities. To have a better understanding of the inhibiting ability of the metallohelices, we determined the Ab40 binding affinity of metallohelices by the fluorescence titration method (14, 34) . With increasing amounts of metallohelices, the fluorescence intensity of Ab40 was decreased ( fig. S8 ). The apparent binding constants (K a ) were extracted by a nonlinear least-squares procedure. As shown in table S2, K a values of LA1 and LB4 were 8.9-fold and 2.3-fold higher than those of their D enantiomers. As previously reported, the K a values of symmetric complexes L1 and L2 are only 3.9 and 5.3 times higher than those of 
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their enantiomers (table S2) . Together, symmetric complexes showed less chiral discrimination on Ab aggregation than asymmetric ones. These results are in agreement with the IC 50 value of the metallohelices against Ab40 aggregation. Therefore, we conjectured that the distinct inhibition ability of these metallohelices mainly depended on the different affinities to Ab40. Although both symmetric and asymmetric metallohelices have similar triple-helical structures, they presented different Ab40 inhibition activities and binding affinities as a result of their different spatial structures. Notably, although the affinities of asymmetric metallohelices to Ab40 were not as strong as those of the Ab antibody (35, 36) , the chiral recognition between these enantiomers was significant for targeting and inhibition of Ab40 aggregation.
The stoichiometry and binding constants between these new inhibitors and Ab40 were estimated by isothermal titration calorimetry (ITC) (14) . The ITC integrated heat data profiles were used to estimate the binding parameters between Ab and LA1, between Ab and DA1, between Ab and LB4, and between Ab and DB4. The binding was exothermic according to the net enthalpy change (fig. S9) (37) and gave the best fit to 1:1 binding. The thermodynamic parameters were summarized in table S3, including the binding constant (K a ), enthalpy change (DH), entropy change (DS), and Gibbs free energy change (DG) upon the interaction between Ab and metallohelices. Binding constants of LA1-Ab40, DA1-Ab40, LB4-Ab40, and DB4-Ab40 were estimated to be 4.93 × 10 , respectively. These analyses further indicated that LB4 had much stronger interactions to Ab40 than its enantiomer DB4.
Ab12-28 and Ab25-35 fragments were used to explore the binding site on Ab40. Given that the metallohelices have a similar size to short a-helical peptides, it was considered that they may bind to the Ab13-23 region. Because the cleavage site of Ab12-28 (lysine residues) was involved in the central hydrophobic region, we chose this fragment as the trypsin substrate for digestion experiments to verify our hypothesis (16) . Figure S10 shows that the digestion of Ab12-28 was prevented by the presence of metallohelices, suggesting that they bind to the a/b discordant stretch of Ab13-23. The band of Ab12-28 incubated with compound B4 remained even stronger than that incubated with A1, demonstrating that B4 bound to Ab40 more tightly than A1. Furthermore, with the incubation of LA1, the band of Ab12-28 was stronger than that with DA1, because the L enantiomer bound to Ab40 more tightly than the D one. On the other hand, previous reports demonstrated that Ab25-35 can also form fibrils as Ab40 (38, 39) . However, the inhibition effect of these metallohelices on Ab25-35 was much weaker than that on Ab40 ( fig. S11 ). The aggregation process was not inhibited completely by the metallohelices even at a high concentration; that is, they bind weakly to Ab25-35.
Nuclear magnetic resonance (NMR) spectroscopy was further used to study the binding site with Ab40 (40) (41) (42) . The 1 H NMR signals of the aromatic rings (F19 and F20) (40, 41) of Ab40 changed significantly upon the addition of A1, revealing that the triplex bound to the central hydrophobic region of Ab40 (Fig. 5, A to D) . Moreover, compared with the NMR spectrum of Ab40 alone, obvious peak shifts were observed with the incubation of A1 in 2.95 and 2.52 parts per million owing to the amide protons of K16 and E22, respectively (Fig. 5 , B and C) (42, 43) . LA1 induced the peaks to move to downfield, whereas DA1 led to a shift to upfield, suggesting a binding difference between LA1 and DA1 with Ab40.
Fourier transform infrared (FTIR) spectroscopy is one of the powerful methods to study the structure of peptides. Figure S12 shows the FT-IR spectra of Ab40 under different conditions. The amide I and amide II regions (1750 to 1500 cm −1 ) play a key role in analyzing the second structure of the peptide. As shown in the FTIR spectra of the Ab40 fibril, the signals at 1620 cm −1 can be assigned to antiparallel b sheets, whereas the band at 1680 cm −1 can be assigned to b turns, in agreement with previous reports (44, 45) . For Ab40 incubated with metallohelices, the signals at 1620 cm −1 slightly shift to lower frequencies. The band at 1650 cm −1 can be assigned to a helices, together 
with a small contribution from random coils and unstructured conformations. As for the Ab40 monomer, the band around 1440 cm
can be assigned to His residues (46) . After the conversion of the Ab40 monomer to fibril, His residues became involved in the b sheet structure and their vibrations became limited. Therefore, its vibrational band can hardly be observed. With the incubation of metallohelices (LA1 and DA1), the vibrational band of His residues is observable, demonstrating that the metallohelices (LA1 and DA1) can inhibit Ab to form b sheet structures and fibrils.
The 14 ). The chirality of the a-helical structure and L-amino acids of the peptides would result in different hydrophobic and p-p interactions between Ab40 and the D/L enantiomers. Furthermore, the positive charge of the metallohelices also strengthens the binding affinity to negatively charged Ab13-16 by electrostatic interactions.
To better understand and visualize the interactions responsible for such binding of triplex metallohelices, we performed docking studies based on the reported NMR structure of the Ab40 monomer [Protein Data Bank (PDB) 2LFM] in aqueous solution using AutoDock Vina (8, 47, 48) . Under these conditions, the Ab40 peptide comprises a 3 10 helix structure in the 13 to 23 region ( fig. S13) (43) . Figure 6A and fig. S14 show the resultant low-energy conformations of the Ab40-metallohelix interactions. LB4 was parallel to the a helix, and the binding was further stabilized by p-p stacking between F19 and LB4 (Fig. 6, C and D) . Although DB4 also formed p-p stacking with residue F19 (Fig. 6, E and F) , it was perpendicular to the a helix, and the involved p-p stacking moiety was smaller than that of LB4. This is at least consistent with the weaker binding and less potent inhibition observed in the above ITC and ThT studies. The docking studies reported here are also in agreement with the NMR observation that the triplex metallohelices bind to the hydrophobic region.
It has been proposed that Ab aggregation-induced overgeneration of reactive oxygen species (ROS), and the subsequent detrimental reactions with biomacromolecules including proteins, lipids, DNA, and RNA in the cortex, is a factor in AD pathogenesis (49) (50) (51) . Superoxide dismutase (SOD) enzymes are promising pharmaceuticals in the treatment of AD. In addition, it is well known that catalase and SOD activity can be achieved by certain metal-containing model compounds, such as iron porphyrins (52) . Although the Fe(II) center in our metallohelices is highly stabilized in this oxidation state and fully encapsulated in the structure, we know that imine complexes of redox-active metals can nevertheless be radical scavengers (53, 54) . Therefore, we conjectured that the metallohelices used here may be delivering Fe ions in such a form as to display SOD-like activity or are otherwise depleting harmful ROS.
The SOD activities of these metallohelices were estimated by a modified nitro blue tetrazolium (NBT) assay system, 2,2-azinobis(3-ethylbenzothiozoline)-6-sulfonic acid (ABTS) methodology, and cyclic voltammetry (CV) (8, (55) (56) (57) . With the irradiation of light, NBT can be photochemically oxidized by the superoxide anion produced by riboflavin. These metallohelices inhibit this process by reducing the superoxide anion radical. Owing to the distinct absolute configurations, the metallohelices showed different SOD mimic activities ( fig. S15A ). Using the ABTS methodology (56) , the results also demonstrated that the metallohelices scavenged ROS effectively ( fig. S15, B to F) . In addition, we also used CV to assess the reactivity of metallohelices with superoxide (57) . As shown in fig. S16 , after the addition of the metallohelix solution, the oxidation peak current of O 2
•− (I pa : anodic current; oxygen regeneration) decreased, whereas the reduction current (I pc : cathodic current; O 2
•− formation) was nearly unchanged. These data indicated that the metallohelices reacted with O 2
•−
; that is, they scavenged O 2
. Next, we further studied the effects of the metallohelices on superfluous ROS induced by the aggregation of Ab40 in PC12 cells. Our data revealed that the metallohelices effectively suppressed the Ab40-induced ROS production ( fig. S17 ). On the basis of these results, the metallohelices could serve as SOD mimics or otherwise as free radical scavengers.
On the basis of the capacities of the metallohelices to inhibit Ab40 assembly, these complexes might be helpful in protecting cells from Ab-mediated toxicity. Therefore, we performed MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay to probe the cellular metabolism of differentiated PC12 cells, which have been proven to be more susceptible to neurotoxicity of Ab40 aggregations than normal PC12 cells (29) . Before the following experiments, the stability of the complex should be studied under physiological conditions. Upon incubation in phosphate-buffered saline (PBS), the absorption wavelength and the intensity of the metal-to-ligand charge transfer bands of the metallohelices did not change ( fig. S18) , demonstrating that the metallohelices were stable under our experimental conditions. Further studies showed that A1 or B4 alone had little influence on PC12 cell viability ( fig. S19 ). As shown in fig. S20 , aged Ab40 and Ab42 caused a decrease in cell viability. With the addition of A1 or B4, cell death can be suppressed in a dose-dependent manner. As a result of the different binding affinities to Ab40 and Ab42, these metallohelices showed chiral discrimination even in the culture medium. Although B4 displayed higher binding affinity to Ab40, it only showed a lightly stronger protection effect than A1, suggesting that Ab-mediated cytotoxicity was complicated when Ab40 and the metallohelices were incubated together.
The transgenic Caenorhabditis elegans (C. elegans) strain CL2006, which expresses an Ab protein fragment involved in the development of AD, is widely used in studying and developing drug effects (58, 59) . The strain shows a phenotype of Ab expression and aggregation in muscle, leading to progressive paralysis. In untreated control C. elegans, the worms were almost completely paralyzed within 12 days; by comparison, the paralysis rate induced by Ab was obviously postponed in CL2006 worms with the treatment of metallohelices. Complete paralysis occurred in 13 days with the incubation of DA1, whereas the worms were completely paralyzed within 15 days with LA1 treatment (Fig. 7A) . In addition, both LB4 and DB4 can also delay the paralysis of CL2006 worms to about 16 days (Fig. 7B) . These data show that metallohelix treatment led to an increased life span in this strain.
Moreover, to investigate whether life-span extension was related to Ab accumulation, thioflavin S (ThS) staining was performed to estimate the amyloid levels in the CL2006 strain (59) . N2 wild-type strain worm was used as a control, which did not express Ab transgene or undergo paralysis. The fluorescent images of the head region are shown in Fig. 7 (C to H) . The images showed that metallohelix treatment greatly inhibited Ab aggregation and deposition in the CL2006 strain compared with the untreated CL2006 worms. These findings demonstrated that metallohelices extend the life span of C. elegans by attenuating Ab-induced toxicity.
As potential therapeutic agents for the treatment of AD, these metallohelices should cross the blood-brain barrier (BBB). Metallohelix permeability of the BBB is evaluated by the quantity of Fe in the mouse brain through inductively coupled plasma mass spectrometry (ICP-MS). Compared to the control mouse, a higher level of Fe can be detected in the cerebrospinal fluid (CSF) of metallohelix-treated mouse. About 1.68 and 0.82% for A1 and B4, respectively, can be accumulated in the brain effectively, suggesting that these metallohelices had the ability to cross the BBB. Briefly, these metallohelices can be potential candidates for AD treatment. Moreover, compared with B4, A1 exhibited a stronger capability to cross the BBB.
CONCLUSION
In summary, asymmetric triplex metallohelices have been demonstrated to provide a new generation of chiral Ab inhibitors. Through binding to a/b discordant stretches, these architecturally chiral species show enantioselectivity in the inhibition of Ab42 aggregation, evidenced by fluorescent cell-based screening systems and multiple biophysical and biochemical techniques. In addition, the compounds can cross the BBB and block Ab-mediated cellular toxicity. In vivo study proved that these metallohelices extend the life span of the C. elegans CL2006 strain by attenuating Ab-induced toxicity. The modular nature of the synthesis of these triplex systems will allow us to further tune the chiral multivalent interactions we have begun here to characterize. Our work indicates that these new generations of asymmetric chiral supramolecular complexes are viable as Ab inhibitors against AD.
MATERIALS AND METHODS

ThT assay
After incubation for different times, samples of 50 mM Ab40 with or without 50 mM metallohelices were diluted 50-fold with 0.01 M Hepes buffer containing 0.15 M NaCl (pH 7.3). A JASCO FP-6500 spectrofluorometer was used for the ThT fluorescence assay.
[ThT] = 10 mM, l ex = 444 nm, and l em = 482 nm.
Ab-ECFP fusion system
The ECFP and Ab1-42 coding sequences were connected through a short linker DNA. The vector with Ab-linker-ECFP or linker-ECFP transformed to Escherichia coli strain BL21 (DE3) and cultured in LB medium with ampicillin (50 mg/ml) at 37°C. Metallohelices with different concentrations were mixed to the culture medium for 30 min. Then, isopropyl-b-D-thio-galactoside (1 mM) was added to the culture medium to induce the expression of ECFP. The recombinant proteins were expressed at 20°C for 3 hours. After measuring the optical density at 600 nm (OD 600 ) of all the samples, they were diluted to OD 600 = 0.1. Fluorescence measurements were performed with a JASCO FP-6500 spectrofluorimeter. l ex = 433 nm.
CD studies A JASCO J-810 spectropolarimeter was used to collect CD spectra. The experiments were performed at 37°C using a quartz cell with a path length of 1 mm. The spectra of the samples were an average of three scans with a wavelength of 200 to 250 nm and a speed of 5 nm/min. The experimental parameters were set as follows: response, 4 s; interval, 0.1 nm. The samples of Ab and metallohelices were incubated in 0.01 M Hepes buffer with 0.15 M NaCl (pH 7.3) at 37°C for 7 days.
AFM studies
Ab40 with or without equimolar A1 or B4 treatment was incubated at 37°C for 7 days. The Ab40 samples were diluted 50-fold to obtain a concentration of 1 mM with deionized H 2 O. Then, 0.05 ml of the sample was dropped on a newly prepared mica substrate. After incubating for 30 min, the substrate was washed twice with deionized H 2 O and dried before AFM studies. Under ambient conditions, tapping mode was used to obtain the images. [Ab40] = 50 mM.
Trypsin digestion of Ab12-28
Ab12-28 (20 mM, 10 ml) with or without the incubation of A1 and B4 (Ab12-28:[A1 or B4] = 1:1) was reacted with trypsin (0.1 mg/ml) at 37°C for 1 hour. Then, all peptide samples were mixed with SDS-PAGE reducing sample buffer and boiled for 10 min. The SDS-PAGE gels were run in tris-tricine buffer. Finally, the SDS-PAGE gel was stained by silver.
Sedimentation and PAGE Samples of 50 mM Ab40 peptides were treated with or without 50 mM metallohelices at 37°C for 7 days. The samples were centrifuged at 13,500 rpm for 20 min to separate the aggregated Ab40 peptide. The pellets were resuspended and heated to 100°C after mixing the sample buffer with SDS. Samples were run on a tris-tricine SDS gel (12%) for 1 hour at 100 V. Finally, the gel was stained by silver.
NMR spectroscopy
In NMR measurement, peptide samples were prepared in 0.01 M tris buffer (pH 7.3, containing 0.15 M NaCl) with 10% D 2 O added. The concentration of Ab40 samples was 0.1 mM. The Ab40 samples were treated with metallohelices LA1 and DA1 at 37°C for 2 hours. An NMR study was performed on a Bruker AVANCE NMR 600 MHz spectrometer equipped with a triple-channel cryoprobe at 5°C.
[Metallohelices] = 0.1 mM.
FT-IR measurement
The concentration of the Ab40 peptide was 6 mg/ml in D 2 O. The concentration of metallohelices was 1.4 mM in D 2 O. FT-IR spectra were obtained by using a Bio-Rad FTS-40 spectrometer with a HgCdTe detector. Solvent correction was performed by subtracting a spectrum of D 2 O.
Docking studies
We obtained the structure of the Ab40 from the PDB (NMR structure in aqueous solution, PDB 2LFM). Specifically, the structures of Ab40 and the metallohelices (LA1, DA1, LB4, and DB4) were prepared by using AutoDock Tools. The torsion angles of these metallohelices were regarded as flexible. Binding calculations were carried out between Ab40 and the metallohelices by AutoDock Vina. In the docking study, the exhaustiveness for the docking runs was 400. The starting positions of the metallohelices were randomly determined, and 20 modes of docking were obtained during docking. Docked models of the metallohelices with Ab40 were visualized using Discovery Studio.
SOD activity measurement by NBT
The percent inhibition of the photoreduction of NBT can be used to evaluate the SOD activities of the metallohelices. The solutions containing 0.075 mM NBT, 13 mM methionine, 0.02 mM riboflavin, and metallohelices of various concentrations were prepared in 0.05 M PBS (pH 7.8). The samples were irradiated with a lamp for 10 min at room temperature. Immediately, the absorbance of the samples was measured at 560 nm after irradiation. The reaction mixture in an identical tube was kept in the dark, serving as a blank control. The inhibition ability was assessed using the following formula: inhibition (%) = [(A 0 -A)/A 0 ] × 100, where A 0 is the absorbance of the blank control and A is the absorbance of the sample.
Cyclic voltammetry
The electrolytic medium was dimethyl sulfoxide (DMSO) in 100 mM tetrabutylammonium hexafluorophosphate. CV studies were performed with a stationary glassy carbon electrode as the working electrode and platinum wire as the auxiliary electrode. The reference electrode was a Ag/AgCl electrode in saturated KCl solution. Before and after each measurement, we polished the surface of the electrode with alumina powder (0.3 to 0.05 mm). The O 2 /O 2
•− was measured at 0.1 V s −1 by using different metallohelices (20 mM) at 25°C. We bubbled the O 2 gas directly into the cell with DMSO for 20 min. During the CV experiment, O 2 was flushed over the cell solution using an apparatus consisting of two flowmeters (Cole-Parmer 316 SS) for O 2 and N 2 .
Fluorescence titrations
The experimental conditions were listed as follows: [Ab40] = 3 mM, [metallohelices] = 0.5 to 7 mM, l ex = 278 nm, and l em = 306 nm. The binding constants were calculated according to the 1:1 binding stoichiometric equation. To achieve the appropriate intensity values of fluorescence, the inner filter effect needs to be corrected. Attenuation of the excitation beam and emission signal causes the inner filter effect, because the absorption by fluorophore resulted in a decrease in fluorescence intensity. The inner filter effect can be corrected with the absorbance values. Using the following equation, the fluorescence data of the system can be corrected
where F corr and F obs are the corrected and observed intensity of fluorescence, respectively, and A ex and A em are the absorbance at the excitation and emission wavelength, respectively.
ITC studies
Titrations were carried out in 10 mM Hepes buffer (pH 7.4, containing 150 mM NaCl). An ITC study was carried out on a Nano ITC System (TA Instruments Inc.). Injections of 10-ml 0.45 mM metallohelices (LA1, DA1, LB4, and DB4) were mixed by a computer-controlled microsyringe at an interval of 10 min into the 0.020 mM Ab40 solution, with stirring at 400 rpm at a constant temperature of 25°C.
NanoAnalyze software was used to analyze the experimental data (TA Instruments Inc.). A blank model was used to correct the heat of dilution. In addition, the experimental data were acquired by 25 injections of 0.45 mM metallohelices into 1400 ml of Ab at a constant temperature of 25°C. As a result of each 10-ml metallohelix injected into the Ab40 aqueous solution, a heat-burst curve was obtained.
Stopped-flow experiments
Fluorescence stopped-flow experiments were performed by using an SX20 Stopped-Flow Spectrometer (Applied Photophysics Limited). The final concentration of Ab and metallohelices (LA1 and DA1) was 25 mM. Fluorescence changes were monitored at 306 nm with an excitation wavelength of 278 nm. MTT assay PC12 cells from a rat pheochromocytoma were obtained from the American Type Culture Collection. They were cultured in Dulbecco's minimum essential medium (Gibco) with 10% heat-inactivated horse serum and 5% fetal bovine serum. PC12 cells were cultured in a humidified atmosphere of 95% air and 5% CO 2 at 37°C. Differentiated PC12 cells were obtained by adding nerve growth factor (50 mg/ml; Invitrogen). The PC12 cells were seeded at 3 × 10 4 cells per well on 96-well plates for 24 hours. Ab40 (5 mM) aged in the absence or presence of metallohelices was added into the cultured medium of differentiated PC12 cells, and the cells were cultured for another 24 hours at 37°C. Cytotoxicity was evaluated using the MTT method. Absorbance values were measured with an automatic plate reader at 490 nm. Three independent experiments were carried out for each group.
C. elegans strains
In our study, two kinds of nematodes were used, including the transgenic CL2006 strain and the N2 ancestral strain. Transfected CL2006 worms produce Ab3-42 in the body wall muscles constitutively. The N2 strain is a wild-type strain. The nematode strains were fed with E. coli (OP50) and propagated at 20°C on solid nematode growth medium. To obtain age-synchronized worms, they were transferred to fresh NGM plates after reaching maturity at 3 days. Then, they laid eggs overnight. At day 1, isolated hatchlings were cultured on new NGM plates at 20°C.
C. elegans paralysis assay
Strains (the N2 and CL2006 worms) were cultured at 20°C on new NGM plates (35 × 10 mm culture plates, 50 worms per plate) after egg synchronization. The strains were fed with OP50 E. coli. In the experimental group, the strains were fed with metallohelices (100 mM, 100 ml per plate) at the larval stage (including L1, L2, or L3), and paralysis was estimated at the L4 larval stage. When strains only moved their head or did not move at all when gently touched with a platinum loop, we classified them as paralyzed. Three independent trials were performed.
Fluorescence staining of Ab deposits
For strain CL2006, synchronized populations were cultured in S-basal liquid medium containing metallohelices (100 mM, 100 ml per plate) at 20°C. CL2006 worms were fixed in PBS (pH 7.4, containing 4% paraformaldehyde) for 24 hours at 4°C and rendered permeable in permeabilization buffer [1% Triton X-100, 5% b-mercaptoethanol, and 0.125 M tris (pH 7.4)] for another 24 hours at 37°C. After two washings with PBS, the nematodes were immersed in 50% ethanol with 0.125% ThS for 2 min, destained in 50% ethanol, mounted on slides, and analyzed by fluorescence images. At least three independent trials were performed.
Handling of mice Eight-to 12-week-old Wistar rats (sex-randomized) were used as test animals. All animal experiments were carried out according to the principles and procedures in "Regulations for the Administration of Affairs Concerning Laboratory Animals" by the National Council of China and "The National Regulation of China for Care and Use of Laboratory Animals" by the National Science and Technology Commission of China. Protocols were approved by the Committee of Jilin University Institutional Animal Care and Use. Wistar rats were dissected after intraperitoneal injection of metal complexes for 4 hours. After anesthesia and exposure of the cisterna magna, CSF was obtained using a glass-pulled micropipette, ensuring that the CSF was not contaminated with blood. About 10 ml of the CSF was obtained. The CSF was immediately diluted 10-fold in 1% CHAPS (3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate) in PBS with protease inhibitors (Roche Diagnostics). The iron content of the samples was measured by ICP-MS (Varian 720-ES).
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